{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:26:21Z","timestamp":1785878781816,"version":"3.56.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001407","name":"Department of Biotechnology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["BT\/PR39876\/BTIS\/137\/7\/2021"],"award-info":[{"award-number":["BT\/PR39876\/BTIS\/137\/7\/2021"]}],"id":[{"id":"10.13039\/501100001407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ISRM\/12(10)\/2019"],"award-info":[{"award-number":["ISRM\/12(10)\/2019"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020703","name":"Department of Pharmaceutical Sciences, St. John's University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020703","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/j.ijbiomac.2023.124749","type":"journal-article","created":{"date-parts":[[2023,5,7]],"date-time":"2023-05-07T09:43:38Z","timestamp":1683452618000},"page":"124749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"P1","title":["Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach"],"prefix":"10.1016","volume":"242","author":[{"given":"Gera","family":"Narendra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baddipadige","family":"Raju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshu","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subheet Kumar","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurleen Kaur","family":"Tung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasdeep","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satwinderjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharti","family":"Sapra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Om","family":"Silakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.124749_bb0005","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s00280-016-3152-1","article-title":"The effect of cyclophosphamide on the immune system: implications for clinical cancer therapy","volume":"78","author":"Ahlmann","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0010","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.3389\/fimmu.2020.01376","article-title":"Delicate balances in cancer chemotherapy: modeling immune recruitment and emergence of systemic drug resistance","author":"Tran","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0015","first-page":"141","article-title":"Drug resistance and combating drug resistance in cancer","volume":"2","author":"Wang","year":"2019","journal-title":"Cancer Drug Resist."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124749_bb0020","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/07388551.2015.1015957","article-title":"Molecular mechanisms of drug resistance and its reversal in cancer","volume":"36","author":"Kartal-Yandim","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0025","first-page":"1","article-title":"Multiple machine learning, molecular docking, and ADMET screening approach for identification of selective inhibitors of CYP1B1","author":"Raju","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.124749_bb0030","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/03602532.2019.1632886","article-title":"Drug metabolizing enzymes-associated chemo resistance and strategies to overcome it","volume":"51","author":"Verma","year":"2019","journal-title":"Drug Metab. Rev."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124749_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-7364-5-4-283","article-title":"Update on the aldehyde dehydrogenase gene (ALDH) superfamily","volume":"5","author":"Jackson","year":"2011","journal-title":"Hum. Genomics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.124749_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1479-7364-2-2-138","article-title":"Analysis and update of the human aldehyde dehydrogenase (ALDH) gene family","volume":"2","author":"Vasiliou","year":"2005","journal-title":"Hum. Genomics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.124749_bb0045","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1124\/pr.59.2.1","article-title":"Neurotoxicity and metabolism of the catecholamine-derived 3, 4-dihydroxyphenylacetaldehyde and 3, 4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase","volume":"59","author":"Marchitti","year":"2007","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0050","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/978-3-319-09614-8_20","article-title":"The effects of alcohol and aldehyde dehydrogenases on disorders of hematopoiesis","author":"Smith","year":"2015","journal-title":"Biol. Basis Alcohol Induc. Cancer"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.124749_bb0055","doi-asserted-by":"crossref","first-page":"921","DOI":"10.7150\/ijbs.42300","article-title":"Aldehyde dehydrogenase, liver disease and cancer","volume":"16","author":"Wang","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0060","series-title":"Induction of Cyclophosphamide-resistance by Aldehyde-dehydrogenase Gene Transfer","author":"Magni","year":"1996"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124749_bb0065","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/03602530500364023","article-title":"Metabolism and transport of oxazaphosphorines and the clinical implications","volume":"37","author":"Zhang","year":"2005","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124749_bb0070","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/03602532.2021.1874406","article-title":"Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review","volume":"53","author":"Raju","year":"2021","journal-title":"Drug Metab. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124749_bb0075","doi-asserted-by":"crossref","first-page":"523","DOI":"10.3892\/mmr.2017.6636","article-title":"Investigating critical genes and gene interaction networks that mediate cyclophosphamide sensitivity in chronic myelogenous leukemia","volume":"16","author":"He","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.103979","article-title":"Investigating the role of missense SNPs on ALDH 1A1 mediated pharmacokinetic resistance to cyclophosphamide","volume":"125","author":"Verma","year":"2020","journal-title":"Comput. Biol. Med."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.124749_bb0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12032-021-01569-9","article-title":"Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis","volume":"38","author":"Narendra","year":"2021","journal-title":"Med. Oncol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.124749_bb0090","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1002\/stem.299","article-title":"Inhibition of aldehyde dehydrogenase expands hematopoietic stem cells with radioprotective capacity","volume":"28","author":"Muramoto","year":"2010","journal-title":"Stem Cells"},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.124749_bb0095","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1021\/acs.jmedchem.5b00577","article-title":"Discovery of NCT-501, a potent and selective theophylline-based inhibitor of aldehyde dehydrogenase 1A1 (ALDH1A1)","volume":"58","author":"Yang","year":"2015","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.124749_bb0100","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1021\/jm401377v","article-title":"Development of selective inhibitors for aldehyde dehydrogenases based on substituted indole-2, 3-diones","volume":"57","author":"Kimble-Hill","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0105","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cbi.2014.12.038","article-title":"Discovery of a series of aromatic lactones as ALDH1\/2-directed inhibitors","volume":"234","author":"Buchman","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124749_bb0110","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1021\/jm501900s","article-title":"Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors","volume":"58","author":"Morgan","year":"2015","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.124749_bb0115","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1021\/acs.jmedchem.8b00270","article-title":"Discovery of orally bioavailable, quinoline-based aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with potent cellular activity","volume":"61","author":"Yang","year":"2018","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.124749_bb0120","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1021\/acscentsci.8b00313","article-title":"Surveillance of cancer stem cell plasticity using an isoform-selective fluorescent probe for aldehyde dehydrogenase 1A1","volume":"4","author":"Anorma","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0125","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0130","first-page":"1","article-title":"Drug repurposing for Alzheimer\u2019s disease: in silico and in vitro investigation of FDA-approved drugs as acetylcholinesterase inhibitors","author":"Kumar","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"612","key":"10.1016\/j.ijbiomac.2023.124749_bb0135","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd5524","article-title":"Drug repurposing: misconceptions, challenges, and opportunities for academic researchers","volume":"13","author":"Begley","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107950","article-title":"Multiple machine learning models combined with virtual screening and molecular docking to identify selective human ALDH1A1 inhibitors","volume":"107","author":"Narendra","year":"2021","journal-title":"J. Mol. Graph. Model."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124749_bb0145","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\u2212 a free database of commercially available compounds for virtual screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf. Model."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124749_bb0150","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1002\/jcc.21707","article-title":"PaDEL-descriptor: an open source software to calculate molecular descriptors and fingerprints","volume":"32","author":"Yap","year":"2011","journal-title":"J. Comput. Chem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124749_bb0155","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1093\/nar\/28.1.235","article-title":"The protein data bank","volume":"28","author":"Berman","year":"2000","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124749_bb0160","doi-asserted-by":"crossref","first-page":"100324","DOI":"10.1016\/j.jaim.2020.05.009","article-title":"In silico computational screening of kabasura kudineer-official siddha formulation and JACOM against SARS-CoV-2 spike protein","volume":"13","author":"Kiran","year":"2020","journal-title":"J. Ayurveda Integr. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.124749_bb0165","doi-asserted-by":"crossref","DOI":"10.1063\/1.3519057","article-title":"A water-swap reaction coordinate for the calculation of absolute protein\u2013ligand binding free energies","volume":"134","author":"Woods","year":"2011","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0170","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1039\/C3FD00125C","article-title":"Rapid decomposition and visualisation of protein\u2013ligand binding free energies by residue and by water","volume":"169","author":"Woods","year":"2014","journal-title":"Faraday Discuss."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124749_bb0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0170937","article-title":"A high-content assay enables the automated screening and identification of small molecules with specific ALDH1A1-inhibitory activity","volume":"12","author":"Yasgar","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.124749_bb0180","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1021\/jm401508p","article-title":"Selective ALDH3A1 inhibition by benzimidazole analogues increase mafosfamide sensitivity in cancer cells","volume":"57","author":"Parajuli","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112940","article-title":"Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors","volume":"209","author":"Li","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.124749_bb0190","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202200108","article-title":"3D-QSAR and scaffold hopping based designing of benzo [d] ox-azol-2 (3H)-one and 2-oxazolo [4, 5-b] pyridin-2 (3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: synthesis and biological evaluation","volume":"355","author":"Verma","year":"2022","journal-title":"Arch. Pharm."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0195","series-title":"High-dose Etoposide and Cyclophosphamide Without Bone Marrow Transplantation for Resistant Hematologic Malignancy","author":"Brown","year":"1990"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.124749_bb0200","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/2053369115599090","article-title":"Selective estrogen receptor modulators and the combination therapy conjugated estrogens\/bazedoxifene: a review of effects on the breast","volume":"21","author":"Pickar","year":"2015","journal-title":"Post Reprod. Health"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.124749_bb0205","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.124749_bb0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.maturitas.2009.06.006","article-title":"Bazedoxifene\/conjugated estrogens and quality of life in postmenopausal women","volume":"63","author":"Utian","year":"2009","journal-title":"Maturitas"},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0215","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cbi.2014.10.028","article-title":"Development of a high-throughput in vitro assay to identify selective inhibitors for human ALDH1A1","volume":"234","author":"Morgan","year":"2015","journal-title":"Chem. Biol. Interact."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.124749_bb0220","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/bab.2150","article-title":"A comprehensive review on anticancer mechanism of bazedoxifene","volume":"69","author":"Zafar","year":"2022","journal-title":"Biotechnol. Appl. Biochem."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.124749_bb0225","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1080\/13697137.2021.1936485","article-title":"Selective estrogen receptor modulators and bone health","volume":"25","author":"Goldstein","year":"2022","journal-title":"Climacteric"},{"issue":"13","key":"10.1016\/j.ijbiomac.2023.124749_bb0230","doi-asserted-by":"crossref","first-page":"15460","DOI":"10.18632\/oncotarget.7102","article-title":"Potential therapeutic implications of IL-6\/IL-6R\/gp130-targeting agents in breast cancer","volume":"7","author":"Heo","year":"2016","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.124749_bb0235","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.arcmed.2017.11.012","article-title":"Combined raloxifene and letrozole for breast cancer patients","volume":"48","author":"Vohora","year":"2017","journal-title":"Arch. Med. Res."},{"key":"10.1016\/j.ijbiomac.2023.124749_bb0240","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2021\/e2380","article-title":"Effects of raloxifene combined with low-dose conjugated estrogen on the endometrium in menopausal women at high risk for breast cancer","volume":"76","author":"Carneiro","year":"2021","journal-title":"Clinics"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.124749_bb0245","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1124\/dmd.120.000296","article-title":"Aldehyde oxidase contributes to all-trans-retinoic acid biosynthesis in human liver","volume":"49","author":"Zhong","year":"2021","journal-title":"Drug Metab. Dispos."},{"issue":"34","key":"10.1016\/j.ijbiomac.2023.124749_bb0250","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.18632\/oncotarget.26833","article-title":"Bazedoxifene as a novel strategy for treatment of pancreatic and gastric adenocarcinoma","volume":"10","author":"Burkhardt","year":"2019","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.124749_bb0255","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.21873\/anticanres.15003","article-title":"Synergistic effect of bazedoxifene and PARP inhibitor in the treatment of ovarian cancer regardless of BRCA mutation","volume":"41","author":"Zhang","year":"2021","journal-title":"Anticancer Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.124749_bb0260","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10549-019-05183-2","article-title":"Bazedoxifene is a novel IL-6\/GP130 inhibitor for treating triple-negative breast cancer","volume":"175","author":"Tian","year":"2019","journal-title":"Breast Cancer Res. Treat."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023016434?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023016434?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T06:16:38Z","timestamp":1762236998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023016434"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7]]},"references-count":52,"alternative-id":["S0141813023016434"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124749","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Raloxifene and bazedoxifene as selective ALDH1A1 inhibitors to ameliorate cyclophosphamide resistance: A drug repurposing approach","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.124749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"124749"}}